title: Design of novel inhibitors of aminopeptidases. Synthesis of peptide-derived diamino thiols and sulfur replacement analogues of bestatin.
abstract: Investigations were directed toward inhibition of an aminopeptidase, isolated from rat brain, which has been implicated in the metabolic inactivation of enkephalins. The design rationale and synthesis of novel peptidyl diamino thiol inhibitors of rat brain aminopeptidase are presented, along with accompanying structure-activity analysis. Some of the reported compounds are highly active aminopeptidase inhibitors and possess enzyme inhibitory potency in the nanomolar range (62; I50 = 1 nM). Analysis of the data permits speculations on possible modes of binding of diamino thiols to aminopeptidase. Other investigations were directed toward understanding the mode of enzyme binding of the naturally occurring aminopeptidase inhibitor bestatin. On the basis of published models of enzyme binding, replacement of the C-2 hydroxyl group of bestatin by a sulfhydryl group was anticipated to lead to enhanced inhibition due to a strengthened interaction of this group with enzymic zinc. Contrary to expectations, "thiobestatin" inhibited rat brain aminopeptidase with only the same degree of effectiveness as the corresponding alcohol. Speculations on the possible mode of enzyme-inhibitor binding of bestatin are offered.
authors.affiliation: Squibb Institute for Medical Research, Princeton, New Jersey 08543-4000.
authors.forename: E M
authors.initials: EM
authors.lastname: Gordon
authors.forename: J D
authors.initials: JD
authors.lastname: Godfrey
authors.forename: N G
authors.initials: NG
authors.lastname: Delaney
authors.forename: M M
authors.initials: MM
authors.lastname: Asaad
authors.forename: D
authors.initials: D
authors.lastname: Von Langen
authors.forename: D W
authors.initials: DW
authors.lastname: Cushman
mesh_terms: D000626:Aminopeptidases / Q000037:antagonists & inhibitors*; D000818:Animals; D001665:Binding Sites; D001921:Brain / Q000201:enzymology; D003959:Diamines / Q000138:chemical synthesis* / Q000494:pharmacology; D006868:Hydrolysis; D007930:Leucine / Q000031:analogs & derivatives*; D010455:Peptides / Q000138:chemical synthesis* / Q000494:pharmacology; D051381:Rats; D013329:Structure-Activity Relationship; D013438:Sulfhydryl Compounds / Q000138:chemical synthesis* / Q000494:pharmacology
chemical_list: D003959:Diamines; D010455:Peptides; D013438:Sulfhydryl Compounds; D000626:Aminopeptidases; D007930:Leucine; C012211:ubenimex